Quoin Pharmaceuticals To Initiate Several Investigator-Led Clinical Studies For QRX009 Topical Rapamycin Lotion Application In Pachyonychia Congenita, Gorlin Syndrome, And Tuberous Sclerosis Complex; Company Expects To Submit IND Application To FDA In Q3